Abbott Laboratories (BVMF:ABTT34)

bluebird bio Statistics

Total Valuation

BVMF:ABTT34 has a market cap or net worth of BRL 1.23 trillion. The enterprise value is 1.27 trillion.

Market Cap	1.23T
Enterprise Value	1.27T

Important Dates

The last earnings date was Thursday, July 17, 2025.

Earnings Date	Jul 17, 2025
Ex-Dividend Date	Jul 14, 2025

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	-0.08%
Shares Change (QoQ)	+0.21%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	1.73B

Valuation Ratios

The trailing PE ratio is 16.20 and the forward PE ratio is 23.38.

PE Ratio	16.20
Forward PE	23.38
PS Ratio	5.24
PB Ratio	4.44
P/TBV Ratio	10.91
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 19.29, with an EV/FCF ratio of 34.28.

EV / Earnings	16.68
EV / Sales	5.29
EV / EBITDA	19.29
EV / EBIT	27.43
EV / FCF	34.28

Financial Position

The company has a current ratio of 1.82, with a Debt / Equity ratio of 0.27.

Current Ratio	1.82
Quick Ratio	1.14
Debt / Equity	0.27
Debt / EBITDA	1.14
Debt / FCF	1.99
Interest Coverage	15.68

Financial Efficiency

Return on equity (ROE) is 30.93% and return on invested capital (ROIC) is 8.75%.

Return on Equity (ROE)	30.93%
Return on Assets (ROA)	6.62%
Return on Invested Capital (ROIC)	8.75%
Return on Capital Employed (ROCE)	11.78%
Revenue Per Employee	2.06M
Profits Per Employee	665,710
Employee Count	114,000
Asset Turnover	0.55
Inventory Turnover	2.74

Taxes

Income Tax	-33.13B
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +18.33% in the last 52 weeks. The beta is 0.73, so BVMF:ABTT34's price volatility has been lower than the market average.

Beta (5Y)	0.73
52-Week Price Change	+18.33%
50-Day Moving Average	61.11
200-Day Moving Average	60.23
Relative Strength Index (RSI)	45.74
Average Volume (20 Days)	1,267

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	2.84

Income Statement

In the last 12 months, BVMF:ABTT34 had revenue of BRL 234.89 billion and earned 75.89 billion in profits. Earnings per share was 43.44.

Revenue	234.89B
Gross Profit	132.29B
Operating Income	45.29B
Pretax Income	43.03B
Net Income	75.89B
EBITDA	62.41B
EBIT	45.29B
Earnings Per Share (EPS)	43.44

Balance Sheet

The company has 39.68 billion in cash and 73.40 billion in debt, giving a net cash position of -33.72 billion.

Cash & Cash Equivalents	39.68B
Total Debt	73.40B
Net Cash	-33.72B
Net Cash Per Share	n/a
Equity (Book Value)	276.96B
Book Value Per Share	158.30
Working Capital	60.09B

Cash Flow

In the last 12 months, operating cash flow was 49.24 billion and capital expenditures -12.33 billion, giving a free cash flow of 36.92 billion.

Operating Cash Flow	49.24B
Capital Expenditures	-12.33B
Free Cash Flow	36.92B
FCF Per Share	n/a

Margins

Gross margin is 56.32%, with operating and profit margins of 19.28% and 32.43%.

Gross Margin	56.32%
Operating Margin	19.28%
Pretax Margin	18.32%
Profit Margin	32.43%
EBITDA Margin	26.57%
EBIT Margin	19.28%
FCF Margin	15.72%

Dividends & Yields

This stock pays an annual dividend of 0.74, which amounts to a dividend yield of 1.25%.

Dividend Per Share	0.74
Dividend Yield	1.25%
Dividend Growth (YoY)	19.33%
Years of Dividend Growth	5
Payout Ratio	28.42%
Buyback Yield	0.08%
Shareholder Yield	1.33%
Earnings Yield	6.17%
FCF Yield	3.00%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on November 21, 2022. It was a forward split with a ratio of 3.

Last Split Date	Nov 21, 2022
Split Type	Forward
Split Ratio	3

Scores

BVMF:ABTT34 has an Altman Z-Score of 5.6 and a Piotroski F-Score of 6.

Altman Z-Score	5.6
Piotroski F-Score	6